Sub-zero temperature studies of microsomal cytochrome P-450: Interaction of Fe2+ with oxygen  by Begard, Evelyne et al.
Volume 75. number 1 FEBS LETTERS March 1977 
SUB-ZERO TEMPERATURE STUDIES OF MICROSOMAL CYTOCHROME P-450: 
INTERACTION OF Fe2’ WITH OXYGEN 
Evelyne BEGARD, Pascale DEBEY and Pierre DOUZOU 
U-128 INSERM, BPSO51,34033 Montpellier Cedex, France 
Received 1 February 1977 
1. Introduction 
Part of the mystery underlying the cycle of redox 
states undergone by the microsomal cytochrome 
P-450 during drug hydroxylation was solved by the 
earlier description by Estabrook et al. [l] of a new 
spectral intermediate appearing during the steady- 
state drug oxidation metabolism and attributed to the 
oxy-ferrous cytochrome P-450. This compound has 
a maximum at 440 nm in a difference spectrum and 
was obtained in the presence of hexobarbital as 
hydroxylisable substrate. Later on, an increasing 
interest was oriented towards the ability of cyto- 
chrome P-450 to bind and use organic hydroperoxides 
as combined source of electron and oxygen, either in 
the microsomes or in a reconstituted system [2-41. 
The problem of the interaction of oxygen with 
reduced cytochrome P-450 was reactivated by the 
recent work of Guengerich et al. [S] describing the 
binding kinetics of O2 to highly purified preparation 
of reduced cytochrome and the obtention of at least 
two distinguishable compounds. 
The present work describes two spectrally 
detectable complexes, very similar to thoses of 
Guengerich et al. and obtained by the addition of O2 
to completely reduced intact microsomes at sub-zero 
temperatures. The advantages of such an experimental 
procedure is to allow a slowing down of reaction rates 
and the ‘uncoupling’ of certain processes from the 
preceding or following ones within a multi-reactions 
system. This procedure was already applied to study 
in the microsomes some reactions involving the 
cytochrome P-450, and previously described [6-81. 
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2. Materials and methods 
2.1. Microsomal preparations 
Liver microsomes were prepared from male Wistar 
Albino rats, according to the method of Ernster et al. 
[9]. The animals were treated over 4 days by intra- 
peritoneal injection of phenobarbital (70 mg/kg body), 
and the livers perfused with cold 0.9% NaCl to remove 
hemoglobin. The pellets of microsomes were stored 
frozen at -30°C before use. 
These microsomes were used either directly, or as 
starting material for further solubilisation and purifi- 
cation of the cytochrome P-450, according to the 
method of Lu et aI. [lo] . In the final step of the 
preparation, the solubilized P-450 is stored at -30°C. 
2.2. Experimental procedure 
Microsomes are homogenized and then diluted in 
deoxygenated 0.1 M phosphate buffer pH, 7 [ 1 l] , to 
which an equal volume of deoxygenated ethylene 
glycol is added. The final suspension contains about 
3.5 mg protein/ml and lo4 M hexobarbital. The 
cytochrome P-450 is then reduced at t 10°C in the 
anaerobic cuvette of an Aminco-Chance DW 2 spectro- 
photometer by either dithionite or NADPH 
(5 X lo-’ M final). After full reduction followed by 
the appearance of the broad 445 nm band in the 
difference spectrum (reference reduced by NADI-I), 
the reference cuvette is also fully reduced and the 
baseline of zero absorbance recorded. The two 
cuvettes are then thermostated at the same sub-zero 
temperature which may be kept constant (+ 0.5’C) 
through the use of an equipment already described [ 121. 
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3. Results 
When the two cuvettes are thermostated at a fmed 
sub-zero temperature, oxygen is bubbled through for 
5-10 s in the sample cuvette and the solutions are 
allowed to stand 20 s to allow a perfect thermal and 
optical stability of the suspension. The first difference 
spectrum (Fe* t O2 minus Fe”) thus obtained at 
-45°C is characterized by an increased absorption at 
430 nm and 450 nm, as well as by a 415 nm peak and 
a 425 nm trough (fig.la). The 430 nm peak decreases 
slowly with time, whereas the 455 nm absorbance 
remains table within 30 min. In the mean time the 
amplitudes of the 415 nm peak and 425 nm trough 
increase continuously. 
At -20°C (fig.1 b) the 430 nm peak is very small 
on the first spectrum, if existing, and the 450 nm 
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Fig. 1. Difference spectra obtained after addition of oxygen 
to a reduced microsomal suspension (- 3 mg protein/ml) 
@ at -45”C, @ at -20°C. Fig.la. Spectra are obtained 
respectively at (1) 30 s, (2) 350 s, (3) 30 min after oxygen 
addition. Fig.lb. Spectra are obtained at (1) 30 s, (2) 170 s, 
and (3) 30 min after oxygen addition. 
absorption decreases now quite rapidly and disappears 
within 30 min. At higher temperatures the 430 nm and 
540 nm peaks cannot be detected by the present 
method which has a rather long dead-time (30 s) and 
the addition of oxygen results in a stable difference 
spectrum with a peak at 415 nm and a trough at 
425 nm. 
When hexobarbital isomitted, qualitatively 
identical, although less intense phenomena re 
observed. Identical spectra re also recorded with a 
partially purified preparation of soluble cytochrome 
P-450, according to the method of Lu et al. [lo] 
and which contains 10% of cytochrome bs but no 
detectable NADH-DCPIP reductase nor NADH-Cyt. 
c reductase activities. Finally separate control 
experiments at the same temperatures show that this 
spectral evolution cannot be observed when N2 is 
bubbled instead of O1 and is not due to an evolution 
of the reference cuvette during the same time. In 
addition, if the same experiment is performed with 
a non anaerobically NADPH-reduced preparation 
where only cytochrome bs is reduced, no optical 
difference is recorded upon oxygen addition. 
4. Discussion 
The present optical spectra obtained at sub-zero 
temperature after addition of oxygen to fully reduced 
microsomes or solubilized cytochrome P-450 are 
noteworthy similar to those obtained recently by 
Guengerich et al. [5] at room temperature with 
highly purified ferrocytochrome P450 from rabit- 
liver microsomes. These authors have describes two 
successive compounds; the first one (Complex I) is 
characterized by two absorption maxima t respectively 
430 nm and 455 nm and is progressively transformed 
into a second one (Complex II) having only a broad 
maximum around 440 nm. Such a maximum in the 
difference spectrum is also characteristic of the new 
compound escribed by Estabrook [l] during the 
steady-state drug oxidation metabolism, and could be 
tentatively attributed to an oxy-ferro complex of 
cytochrome P-450. 
The half time for Complex I formation is still less 
than 30 s at -4O“C, since we do not detect its 
formation kinetics. This is not surprising since the 
k-value is estimated to be 6 X lo4 M-’ s-l at room 
53 
Volume 75, number 1 FEBS LETTERS March 1977 
temperature. More surprising is the quite fast 
decomposition of Complex I into Complex II which 
occurs even at -4O”C, as well as the instability of 
Complex II at -2O”C, owing to the quite slow rates 
of these steps, 2 10 m-l and 12 mn-’ , respectively, 
for the solubilized cytochrome at room temperature. 
Our results imply that, either the activation energies 
of both processes are relatively low, or other factors 
influence the decomposition rate, such as the source 
of microsomes, the state of the cytochrome (mem- 
brane-bound or solubilized), or yet the presence of 
other components of the hydroxylating chain in the 
intact microsomes (flavoproteins or cytochrome bs). 
These could play a role similar to the effector role 
of the putidaredoxin in the bacterial methylene 
hydroxylase system [13]. Indeed the 415 nm peak 
and 425 nm trough in the difference spectra indicate 
that the cytochrome b5 is reoxidized during the 
complex formation and decomposition process, a 
result not obtained with the soluble system [5]. 
If one continues the comparison with the bacterial 
system, the enzymatic decomposition of the oxy- 
genated cytochrome P-450 by the reduced putida- 
redoxin is mono-phasic with a half-time of 80 s at 
-40°C, that is even faster than the decomposition of 
Complex I in the microsomes [ 151. 
We must recall that at the temperature of the 
experiments, the electron-flow from NADPH towards 
either the oxidized cytochrome P-450 or cytochrome 
b5 is stopped in the intact microsomes, so that only 
one turnover of the cytochrome is recorded [ 141. 
This further strengthens the idea that the observed 
spectra are solely due to the interaction of cytochrome 
P-450 with oxygen, without interference of any other 
component. This property was already used to study 
the release of oxidizing species by cytochrome P-450 
after its reaction with oxygen at sub-zero temperature 
under identical conditions [8]. Thus a direct 
comparison of these experiments with the present 
ones is easy and suggests that oxidizing species are 
released from the decomposition of Complex II and 
not from Complex I which would decompose at 
lower temperatures. The Complex I + Complex II 
transformation could thus correspond to a redistribu- 
tion of electrons within the same complex, while 
Complex II decomposition would be related to 
changes in the redox state. 
A closer analysis of the kinetics of these processes 
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in connection with the cytochrome b5 reoxidation 
are clearly needed and should help to the understanding 
of the exact structure and decomposition mechanisms 
of these compounds. For such studies in the intact 
microsomes as well as in the solubilized system, 
experiments at low temperatures appear quite useful. 
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